title: Is preoperative chemoradiation with paclitaxel and carboplatin a new standard of treatment for esophageal cancer?
authors: Department of Gastrointestinal Oncology, Centre Oscar Lambret and Catholic University, Lille, France. a-adenis@o-lambret.fr
authors: Antoine
authors: A
authors: Adenis
authors: Xavier
authors: X
authors: Mirabel
authors: Christophe
authors: C
authors: Mariette
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000592:standards / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000628:therapy*; D059186:Chemoradiotherapy, Adjuvant / Q000009:adverse effects / Q000592:standards*; D002986:Clinical Trials as Topic; D004938:Esophageal Neoplasms / Q000473:pathology / Q000628:therapy*; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage; D011300:Preoperative Care / Q000592:standards*; D017564:Radiation Pneumonitis / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D016190:Carboplatin; D017239:Paclitaxel